Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ranolazine in Diastolic Heart Failure (RALI-DHF)

This study has been completed.
Sponsor:
Collaborator:
University Medicine Göttingen, Cardiac Center
Information provided by (Responsible Party):
Gilead Sciences
ClinicalTrials.gov Identifier:
NCT01163734
First received: July 12, 2010
Last updated: July 11, 2012
Last verified: March 2011